Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

Reduced-intensity conditioning has extended the use of allogeneic hematopoietic stem cell transplantation (HSCT) to patients otherwise not eligible for this treatment due to older age or frailty. One hundred twelve acute myelogenous leukemia/myelodysplastic syndromes patients received fludarabine an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Oran, Betul, Giralt, Sergio, Saliba, Rima, Hosing, Chitra, Popat, Uday, Khouri, Issa, Couriel, Daniel, Qazilbash, Muzaffar, Anderlini, Paolo, Kebriaei, Partow, Ghosh, Shubhra, Carrasco-Yalan, Antonio, de Meis, Ernesto, Anagnostopoulos, Athanasios, Donato, Michele, Champlin, Richard E., de Lima, Marcos
Médium: Artigo
Jazyk:Inglês
Vydáno: 2007
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080636/
https://ncbi.nlm.nih.gov/pubmed/17382251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2006.11.024
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky